Antiparasitic Drug Repurposing Research for Parkinson's Disease

Research into antiparasitic drug repurposing research approaches for Parkinson's Disease. AI-powered analysis of mechanisms, evidence, and clinical status.

About Antiparasitic Drug Repurposing Research

Investigation into repurposing antiparasitic drugs for cancer and neurological conditions. AI agents analyze fenbendazole, ivermectin, and mebendazole mechanisms and clinical evidence.

About Parkinson's Disease

2026 Parkinson's treatment advances: alpha-synuclein targeting, LRRK2 gene therapy, nicotinamide riboside trials. AI-analyzed with safety scores.

Standard of Care: Levodopa/Carbidopa, dopamine agonists, MAO-B inhibitors, deep brain stimulation — primarily dopamine replacement and symptom control.